Zealand Pharma enters AI partnership with Iktos

The French startup specialized in using artificial intelligence in drug design will help Zealand Pharma investigate new potential peptide-based drugs.
Photo: Zealand Pharma / PR
Photo: Zealand Pharma / PR
by mikkel aabenhus hemmingsen, translated by daniel pede

Danish pharmaceutical firm Zealand Pharma is not new to developing peptide-based drugs, but is now adding another tool to its toolbox by partnering up with Iktos, a French startup company specialized in artificial intelligence, according to a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading